PE8195A1 - ADMINISTRABLE PHARMACEUTICAL FORMULATION IN ORAL FORM CONTAINING RALOXIFENE - Google Patents
ADMINISTRABLE PHARMACEUTICAL FORMULATION IN ORAL FORM CONTAINING RALOXIFENEInfo
- Publication number
- PE8195A1 PE8195A1 PE1994247411A PE24741194A PE8195A1 PE 8195 A1 PE8195 A1 PE 8195A1 PE 1994247411 A PE1994247411 A PE 1994247411A PE 24741194 A PE24741194 A PE 24741194A PE 8195 A1 PE8195 A1 PE 8195A1
- Authority
- PE
- Peru
- Prior art keywords
- pharmaceutical formulation
- form containing
- oral form
- administrable pharmaceutical
- containing raloxifene
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA FORMA FARMACEUTICA, TAL COMO UN COMPRIMIDO O UNA TABLETA, CARACTERIZADA POR COMPRENDER: 1) RALOXIFENO, ASI COMO SUS ESTERES, ETERES Y SALES UTILES EN EL TRATAMIENTO DE TUMORES PROSTATICOS Y MAMARIOS, POR SER ANTIESTROGENOS NO ESTEROIDES Y ANTIANDROGENOS; 2) UN AGENTE TENSIOACTIVO TAL COMO POLISORBATO 80; 3) UN DILUYENTE SOLUBLE EN AGUA TAL COMO LACTOSA; LA CUAL TIENE UNA MAYOR SOLUBILIDAD EN MEDIO ACUOSOIT REFERS TO A PHARMACEUTICAL FORM, SUCH AS A TABLET OR A TABLET, CHARACTERIZED BY UNDERSTANDING: 1) RALOXIFENO, AS WELL AS ITS ESTERS, ETHERS AND SALTS USEFUL IN THE TREATMENT OF NON-CONTROLLED PROSTATIC TUMORS; 2) A SURFACE AGENT SUCH AS POLYSORBATE 80; 3) A THINNER SOLUBLE IN WATER SUCH AS LACTOSE; WHICH HAS A GREATER SOLUBILITY IN AQUEOUS MEDIUM
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20491594A | 1994-03-02 | 1994-03-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE8195A1 true PE8195A1 (en) | 1995-04-14 |
Family
ID=40909519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE1994247411A PE8195A1 (en) | 1994-03-02 | 1994-07-25 | ADMINISTRABLE PHARMACEUTICAL FORMULATION IN ORAL FORM CONTAINING RALOXIFENE |
Country Status (6)
Country | Link |
---|---|
KR (1) | KR100335580B1 (en) |
CO (1) | CO4340620A1 (en) |
MY (1) | MY117590A (en) |
PE (1) | PE8195A1 (en) |
TW (1) | TW327604B (en) |
UA (1) | UA39946C2 (en) |
-
1994
- 1994-07-22 TW TW083106737A patent/TW327604B/en active
- 1994-07-25 PE PE1994247411A patent/PE8195A1/en not_active Application Discontinuation
- 1994-07-27 CO CO94032770A patent/CO4340620A1/en unknown
-
1995
- 1995-02-27 MY MYPI9500500 patent/MY117590A/en unknown
- 1995-02-28 UA UA95028203A patent/UA39946C2/en unknown
- 1995-03-02 KR KR1019950004263D patent/KR100335580B1/en active
Also Published As
Publication number | Publication date |
---|---|
CO4340620A1 (en) | 1996-07-30 |
TW327604B (en) | 1998-03-01 |
MY117590A (en) | 2004-07-31 |
KR100335580B1 (en) | 2002-11-30 |
UA39946C2 (en) | 2001-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU90297I2 (en) | Rivastigmine its pharmaceutically acceptable salts and derivatives, in particular rivastigmine in the form of hydrogen tartrate | |
PA8509001A1 (en) | DOSAGE FORM OF DRUGS DRIVEN BY A HYDROGEL | |
UY27682A1 (en) | PHARMACEUTICAL COMPOSITIONS | |
ES2074124T3 (en) | COMPOSITION IN THE FORM OF A FOAM CONTAINING 5-AMINOSALICYLIC ACID FOR INTRA-RECTAL ADMINISTRATION. | |
ES2095964T3 (en) | A COMPOSITION OF LIQUID EXCIPIENT THAT FORMS A GEL. | |
AR025487A2 (en) | COMMERCIAL ARTICLE THAT INCLUDES A CONTAINER CONTAINING A WATERPROOF CLEANING SOLUTION THAT CLEANS AND REDUCES A SIGNIFICANT NUMBER OF PRODUCT MICROORGANISMS | |
ES2160693T3 (en) | STABLE FORMULATION OF 10-HYDROXY-7-ETHYL-CAMPTOTECHINE IN THE LACTONE FORM. | |
ES2075468T3 (en) | DRUG SUPPLY VEHICLES SUSPENDED ON A NON-WATER PERFLUORED CARRIER. | |
DE69531790D1 (en) | SHOWER TOWER | |
ZA200108004B (en) | Echinocandin/carbohydrate complexes. | |
ES2080497T3 (en) | BLOCKS FOR CLEANING TOILETS. | |
RS50089B (en) | Ziprasidone suspension | |
CA2429639A1 (en) | Stable azithromycin monohydrate | |
DK0381617T3 (en) | Contact lens disinfectant and cleanser | |
BG106602A (en) | Formulation of substituted benzimidazoles | |
AR006892A1 (en) | USE OF FORMS OF HYALURONIC ACID (HA) FOR THE TREATMENT OF CANCER | |
AR027504A1 (en) | COMPOSITIONS TO DECOLORATE AND HAVE HAIR | |
MX169821B (en) | CREAMY CLEANING COMPOCITIONS | |
PE8195A1 (en) | ADMINISTRABLE PHARMACEUTICAL FORMULATION IN ORAL FORM CONTAINING RALOXIFENE | |
PE33396A1 (en) | COMPOSITION FOR THE TREATMENT OF NICOTINE ANSIA AND / OR ABSTRACT SMOKING SYMPTOMS | |
MX9203188A (en) | BAR COMPOSITION WITH SODIUM CHLORIDE AND STERILE ALCOHOL. | |
ES2176009T3 (en) | USE OF SODIUM CHLORIDE TO REDUCE GASTROINTESTINAL TOXICITY OF COMPETITION DERIVATIVES. | |
JPS5756420A (en) | Bath agent | |
MY130445A (en) | Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone | |
ES2092559T3 (en) | PHARMACEUTICAL FORMULATION CONTAINING PENCICLOVIR. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |